The panel discusses opportunities and challenges for healthcare improvement and value in emerging Asia-Pacific markets. While an emerging middle class and shift to chronic diseases present opportunities, most countries have limited healthcare funding and infrastructure. Governments are reforming systems but face pressure to control costs. Some countries like Korea and Taiwan have adopted health technology assessment (HTA) to balance innovation and resources, but others lack expertise and data for HTA. European examples demonstrate the long-term benefits of balancing cost containment and industrial policy, with HTA integrated over time to improve efficiencies and avoid unintended consequences of short-term measures.
An introductory overview of healthcare across South East Asia and a look at the growing healthcare trends across the region.
Download the presentation by clicking the "Save this presentation" icon above.
An introduction to Myanmar's current healthcare system with an eye on whether the country is ready for meaningful foreign direct investment in the sector.
Amid a general slowdown of the global pharmaceutical market, pharmerging markets continue to be a formidable engine of growth; across Asia, Africa and South America, these markets are boasting a CAGR of 10-14%. At the outer edges of these growing economies are markets identified by IMS Health as “Frontier Markets” – the next big drivers of growth, opportunity and even innovation.
Among the Frontier Markets, Myanmar is capturing the most attention. With the completion of parliamentary elections in early November of 2015, there are positive signs that the momentum for change and market liberalization will accelerate. Indeed, Myanmar resembles the early days of some of today’s leading Asian developing markets such as Vietnam and Indonesia. However, while understanding the similarities is certainly valuable, the temptation to merely duplicate entry strategies and market assumptions should be resisted. Myanmar’s underinvested healthcare infrastructure, sizeable talent gaps, and significant regulatory and affordability hurdles, require an informed approach, and managed expectations. Multinationals will be challenged to re-evaluate what it takes to play, and what it means to win in both the short and long term.
Healthcare services ; pharmaceutical market of myanmarAccord Healthcare
This report consolidates the main developments of the pharmaceutical market in Myanmar over the last decade. Among the APAC Markets, Myanmar is catching the most attention after the Vietnam. The report provides in-depth information on the healthcare medical system & Pharmaceutical market of Myanmar.
As the economy continues to grow in Myanmar, one of the areas that has seen a major overhaul is the healthcare industry. This Research Note from Ipsos Business Consulting explores the healthcare sector in Myanmar, including their healthcare systems and facilities, opportunity sectors and medical tourism.
The 2016 IMS APAC Insight Magazine provide insights to unveils new areas of play, new methodologies and new geographies that are poised to disrupt the healthcare landscape in this region.
Improvement of National Healthcare System in MyanmarSo Pyay
This document presents a study on improving Myanmar's national healthcare system. The study aims to identify factors that strongly affect healthcare system improvement, including technology, budget, training, work environment, provider-patient communication, medical facilities, and patient safety. The author conducts a literature review on challenges facing healthcare systems and adopts a conceptual framework. Hypotheses are tested through surveys of healthcare providers and students, and statistical analysis finds no significant relationships between healthcare system improvement and factors like age, gender, or marital status. The study aims to provide recommendations to Myanmar's Ministry of Health.
This survey of 245 physicians found that an increasing majority now want more traditional pharmaceutical sales representatives visiting them. For primary care physicians, over 50% now want more visits from primary care representatives, the first time a majority have indicated this preference. Physicians also want more specialty representatives and various types of nontraditional representatives. However, they expect representatives to bring high-quality information, including clinical studies and evidence-based medicine. Physicians want helpful disease and product websites as well as virtual and on-demand information, sampling, and support. Their top priority is helping patients access needed medicines and supporting patients, so representatives must communicate effectively to serve these patient-focused needs.
An introductory overview of healthcare across South East Asia and a look at the growing healthcare trends across the region.
Download the presentation by clicking the "Save this presentation" icon above.
An introduction to Myanmar's current healthcare system with an eye on whether the country is ready for meaningful foreign direct investment in the sector.
Amid a general slowdown of the global pharmaceutical market, pharmerging markets continue to be a formidable engine of growth; across Asia, Africa and South America, these markets are boasting a CAGR of 10-14%. At the outer edges of these growing economies are markets identified by IMS Health as “Frontier Markets” – the next big drivers of growth, opportunity and even innovation.
Among the Frontier Markets, Myanmar is capturing the most attention. With the completion of parliamentary elections in early November of 2015, there are positive signs that the momentum for change and market liberalization will accelerate. Indeed, Myanmar resembles the early days of some of today’s leading Asian developing markets such as Vietnam and Indonesia. However, while understanding the similarities is certainly valuable, the temptation to merely duplicate entry strategies and market assumptions should be resisted. Myanmar’s underinvested healthcare infrastructure, sizeable talent gaps, and significant regulatory and affordability hurdles, require an informed approach, and managed expectations. Multinationals will be challenged to re-evaluate what it takes to play, and what it means to win in both the short and long term.
Healthcare services ; pharmaceutical market of myanmarAccord Healthcare
This report consolidates the main developments of the pharmaceutical market in Myanmar over the last decade. Among the APAC Markets, Myanmar is catching the most attention after the Vietnam. The report provides in-depth information on the healthcare medical system & Pharmaceutical market of Myanmar.
As the economy continues to grow in Myanmar, one of the areas that has seen a major overhaul is the healthcare industry. This Research Note from Ipsos Business Consulting explores the healthcare sector in Myanmar, including their healthcare systems and facilities, opportunity sectors and medical tourism.
The 2016 IMS APAC Insight Magazine provide insights to unveils new areas of play, new methodologies and new geographies that are poised to disrupt the healthcare landscape in this region.
Improvement of National Healthcare System in MyanmarSo Pyay
This document presents a study on improving Myanmar's national healthcare system. The study aims to identify factors that strongly affect healthcare system improvement, including technology, budget, training, work environment, provider-patient communication, medical facilities, and patient safety. The author conducts a literature review on challenges facing healthcare systems and adopts a conceptual framework. Hypotheses are tested through surveys of healthcare providers and students, and statistical analysis finds no significant relationships between healthcare system improvement and factors like age, gender, or marital status. The study aims to provide recommendations to Myanmar's Ministry of Health.
This survey of 245 physicians found that an increasing majority now want more traditional pharmaceutical sales representatives visiting them. For primary care physicians, over 50% now want more visits from primary care representatives, the first time a majority have indicated this preference. Physicians also want more specialty representatives and various types of nontraditional representatives. However, they expect representatives to bring high-quality information, including clinical studies and evidence-based medicine. Physicians want helpful disease and product websites as well as virtual and on-demand information, sampling, and support. Their top priority is helping patients access needed medicines and supporting patients, so representatives must communicate effectively to serve these patient-focused needs.
The insights driving superior healthcare
outcomes in Asia Pacific.
Asia-Pacific Insight Magazine brings together IMS Health experts from across the region to engage in conversations about the forces that are shaping healthcare in Asia - and the strategies necessary to surge ahead of the competition
The document provides an overview of Southeast Asian history and culture. It discusses how the Khmer Empire influenced Cambodia and surrounding regions. It also explains how India and China impacted Southeast Asian religions and Vietnam. European colonialism in the 1500s divided the region until independence movements in the 1900s. The Vietnam War involved the US supporting South Vietnam against Communist North Vietnam and their allies in Cambodia and Laos. The brutal Khmer Rouge regime killed over a million Cambodians before being defeated.
This document provides information about the countries that make up Southeast Asia. It introduces each country individually, highlighting their location, key geographical features, demographics, history and culture. In total it covers 11 countries: Myanmar, Thailand, Laos, Vietnam, Cambodia, Malaysia, Singapore, Indonesia, Brunei, The Philippines and East Timor. It aims to familiarize the reader with this region through brief descriptive overviews of each Southeast Asian nation.
This is my report in International Cuisine Lecture. The content is about the food of the South East Asian countries. I hope it can help :)
--cddlr <3
IMS Health’s Thailand GM Amit Backliwal explains the central role that the three government reimbursement schemes play in Thailand’s pharmaceutical market and how recently enacted spending limits on government healthcare schemes have left MNCs struggling to adapt. This new arena makes placement on the National List of Essential Drugs (NLED) critical, say Backliwal. Click to learn how to get your products placed on the NLED.
This document discusses trends in healthcare and their implications. It notes that populations in Denmark, Norway, and Sweden are aging rapidly and becoming more health-focused. Younger generations expect constant improvement in public services like healthcare. New technologies will disrupt healthcare, such as 3D printing, wearables, and digital diagnostics. Patients will become more informed and take a more active role in their own care. The healthcare system will face pressures to improve productivity and efficiency while meeting higher demands and coping with more complex, chronic patients. Pharmaceutical companies must adapt to personalized medicine and shorter drug development cycles.
Europe's Top 5 Effective Leaders in HealthcareV2_compressed (1).pdfinsightscare
‘Europe's Top 5 Effective Leaders in Healthcare’ we highlight the visionary leaders who have made significant contributions to the advancement of healthcare across Europe.
The document discusses key considerations for pharmaceutical companies in marketing new drugs. Successful new product launches are vital, and factors like unmet need, competition, resources, and pricing strategy determine launch success. Traditional promotion through sales reps is inefficient and controversial. Most of the world's population cannot afford treatment, so improved access systems combining public and private efforts could create new market opportunities and benefit public health by widening treatment. The largest growth potential is in emerging economies like China and India.
The document discusses innovations in healthcare to address issues from aging populations and chronic disease management. It notes rising healthcare costs, a need for improved access to specialists, and resource constraints. New technologies like telemedicine, remote monitoring, and mobile access aim to improve care coordination and empower patients while overcoming barriers. Integrated models of care that seamlessly connect providers, payors, and patients show potential to lower costs and raise quality and satisfaction for chronic care patients.
This document describes a weight loss program called Lighten Up that is designed for hospitals, employers, and communities. Lighten Up uses team-based competitions to encourage weight loss and behavior change among participants. It has shown success with over 32,000 participants and a 400% return on investment. The program aims to improve health and reduce healthcare costs. Testimonials praise Lighten Up for yielding results and being a turnkey wellness solution.
Digital health channels are increasingly being used in Asia to supplement information and support for healthcare needs. A survey of 1,238 consumers across 6 Asian markets found that 89% had accessed the internet for healthcare information, primarily about conditions and available treatments. While physicians remain an important source, digital channels provide a way for patients to educate themselves and get support due to time constraints with doctors. The survey showed consumers are open to various digital communication methods from healthcare providers going forward.
Internet marketing involves using websites and online promotional techniques to achieve marketing objectives. It includes using a company website along with search engines, banner ads, and other websites.
The internet can now support the entire marketing process for most businesses. Customers' decision making processes are also significantly impacted by online information. Both patients and doctors now frequently use the internet for health information and research.
WP_WhatPhysiciansWant_2014-2015_BL_WP_00120140514Betsy Lane
This survey of 245 physicians found that an increasing majority now want more traditional pharmaceutical sales representatives visiting them. For primary care physicians, over 50% now want more visits from primary care representatives, the first time a majority have indicated this preference. Physicians also want more specialty representatives and various types of nontraditional representatives. However, they expect representatives to bring high-quality information, including clinical studies and evidence-based medicine. Physicians want helpful disease and product websites as well as virtual and on-demand information, sampling, and support. Their top priority is helping patients access needed medicines and supporting patients, so they want communication and information provided in convenient, focused, and easy-to-use formats.
1) The document discusses implementing preventive healthcare programs in commercial sectors in China to create a healthier workforce. It outlines setting up educational programs to promote lifestyle changes and regular health checks.
2) A three-pronged approach is proposed involving a knowledge center, consultancy center, and planning center focused on education, monitoring, and implementation. This includes collecting health data, providing lifestyle advice and follow-up programs.
3) The presenter offers to help design educational programs, set up data collection systems, train on data analysis, and solve cultural challenges to transform approaches to preventive healthcare.
This document discusses opportunities for innovation with AVIA. It begins by outlining the author's experience in management, sales, innovation, framework development, planning, and touchpoint management. It then provides examples of cases the author has worked on, including Pfizer and Firestone. The document also summarizes the author's audit of AVIA and its market to develop ideas. It emphasizes that health care delivery needs massive-scale innovation to achieve higher performance and sustainable affordability in the face of rising costs, an aging population, new technologies, and expanding coverage.
The document summarizes the results of a survey on healthcare systems in several European countries and the US. Key findings include:
- Respondents rated their country's healthcare system quality, though Germany, Sweden, and the UK received higher ratings than Italy, Poland and the US.
- Perceptions of doctors' skills and training quality were generally positive, though sharing of information between providers needed improvement.
- Ensuring access for all citizens and managing costs for an aging population will be ongoing challenges for healthcare systems.
- Most respondents felt their country's healthcare industry contributes significantly to economic growth.
The document describes a scenario where the user is the Chief Executive of an NHS trust facing budget shortfalls that put it at risk of closing. There are three main options presented to address the problem: 1) privatize some services, 2) modernize IT systems to improve efficiency, or 3) promote healthy choices to reduce demand. Staff members provide differing perspectives on the options, with concerns about privatization reducing care quality and modernization not solving the ongoing cost of updates. The user must weigh these pros and cons while also considering a growing protest outside over the potential closure to make a final decision on the best approach.
The Sustainable Health Care Facility of the FutureTextbooks H.docxchristalgrieg
The Sustainable Health Care Facility of the Future
Textbooks:
Hayward, C. (2006). Healthcare Facility Planning: Thinking Strategically. Chicago, IL: Health Administration Press.
Vickery, C.G., Nyberg, G., & Whiteaker, D. (2015). Modern Clinic Design: Strategies for an Era of Change. Hoboken, NJ: Wiley.
Instructions: Please ensure to substantiate your response with scholarly sources and/or also a personal account of your own experience in the work place or personal life. Cite and reference work! Must be 150 -200 word count.
What reactions do you have to the ideas they presented? Include examples from the course readings or your own experience to support your perspective, and raise questions to continue the dialogue. 100 to 150 words for questions 1, 2, 6, 9, 10 & 11.
1. I agree that the changes made with CMS (center for Medicare and Medicaid Services) how changed the guidelines for how providers can bill for services. One of the biggest changes was the upgrade of ICD codes which has expanded enormously to be more specific with diagnosis and services to bill for. I work for a program of hospice, called palliative care, and the change over from using ICD9 codes to ICD10 was a very large task that took time to switch over to but I have come to realize that changes in health care are inevitable and to be prepared for things to change constantly. With being a palliative care program I don't think the change was as big of an impact on us like I'm sure it was for a hospital. Our program provides education on disease progress for chronic illnesses such a chronic kidney disease, hypertension, diabetes, cancer, heart disease and so on. The amount of ICD 10 codes we use are minimal compared to what a hospital would see. Nonetheless the codes are way more specific now which can be challenging when trying to narrow down for accuracy.
2. I think training and feedback are two important aspects of implementing electronic medical records. The users are the most important stakeholders and they should be trained properly. Their feedback should be taken seriously as this helps with post implementation changes to the system. No one likes changes but change in any organization is essential. Technology has completely transformed the health care industry and from my experience resistance typically comes from the older generation who doesn't really understand the importance. Most are used to doing things manually. Most organizations are turning to the technology to transform their environment by cutting costs and ensuring that their revenues are coming in timely.
3. Open your web browser and search for videos, articles and other resources discussing the health care system in the United States. Look for new trends, current issues affecting the health care system, etc.
4. Discuss your findings with the class
5. As a healthcare leader, you will need to have a strong base with understanding healthcare systems. Where will health care be delivered in the future? ...
US Healthcare Reform and Impact On Pharma and Healthcare IT CompaniesDr. Susan Dorfman
US Healthcare Reform and Its Impact on Pharma and Healthcare Companies:
Implications Current and Future
Presented at the Edison Ventures Pharma and Healthcare Business Solutions Executive Meeting Lawrenceville, NJ
April 20, 2010
The insights driving superior healthcare
outcomes in Asia Pacific.
Asia-Pacific Insight Magazine brings together IMS Health experts from across the region to engage in conversations about the forces that are shaping healthcare in Asia - and the strategies necessary to surge ahead of the competition
The document provides an overview of Southeast Asian history and culture. It discusses how the Khmer Empire influenced Cambodia and surrounding regions. It also explains how India and China impacted Southeast Asian religions and Vietnam. European colonialism in the 1500s divided the region until independence movements in the 1900s. The Vietnam War involved the US supporting South Vietnam against Communist North Vietnam and their allies in Cambodia and Laos. The brutal Khmer Rouge regime killed over a million Cambodians before being defeated.
This document provides information about the countries that make up Southeast Asia. It introduces each country individually, highlighting their location, key geographical features, demographics, history and culture. In total it covers 11 countries: Myanmar, Thailand, Laos, Vietnam, Cambodia, Malaysia, Singapore, Indonesia, Brunei, The Philippines and East Timor. It aims to familiarize the reader with this region through brief descriptive overviews of each Southeast Asian nation.
This is my report in International Cuisine Lecture. The content is about the food of the South East Asian countries. I hope it can help :)
--cddlr <3
IMS Health’s Thailand GM Amit Backliwal explains the central role that the three government reimbursement schemes play in Thailand’s pharmaceutical market and how recently enacted spending limits on government healthcare schemes have left MNCs struggling to adapt. This new arena makes placement on the National List of Essential Drugs (NLED) critical, say Backliwal. Click to learn how to get your products placed on the NLED.
This document discusses trends in healthcare and their implications. It notes that populations in Denmark, Norway, and Sweden are aging rapidly and becoming more health-focused. Younger generations expect constant improvement in public services like healthcare. New technologies will disrupt healthcare, such as 3D printing, wearables, and digital diagnostics. Patients will become more informed and take a more active role in their own care. The healthcare system will face pressures to improve productivity and efficiency while meeting higher demands and coping with more complex, chronic patients. Pharmaceutical companies must adapt to personalized medicine and shorter drug development cycles.
Europe's Top 5 Effective Leaders in HealthcareV2_compressed (1).pdfinsightscare
‘Europe's Top 5 Effective Leaders in Healthcare’ we highlight the visionary leaders who have made significant contributions to the advancement of healthcare across Europe.
The document discusses key considerations for pharmaceutical companies in marketing new drugs. Successful new product launches are vital, and factors like unmet need, competition, resources, and pricing strategy determine launch success. Traditional promotion through sales reps is inefficient and controversial. Most of the world's population cannot afford treatment, so improved access systems combining public and private efforts could create new market opportunities and benefit public health by widening treatment. The largest growth potential is in emerging economies like China and India.
The document discusses innovations in healthcare to address issues from aging populations and chronic disease management. It notes rising healthcare costs, a need for improved access to specialists, and resource constraints. New technologies like telemedicine, remote monitoring, and mobile access aim to improve care coordination and empower patients while overcoming barriers. Integrated models of care that seamlessly connect providers, payors, and patients show potential to lower costs and raise quality and satisfaction for chronic care patients.
This document describes a weight loss program called Lighten Up that is designed for hospitals, employers, and communities. Lighten Up uses team-based competitions to encourage weight loss and behavior change among participants. It has shown success with over 32,000 participants and a 400% return on investment. The program aims to improve health and reduce healthcare costs. Testimonials praise Lighten Up for yielding results and being a turnkey wellness solution.
Digital health channels are increasingly being used in Asia to supplement information and support for healthcare needs. A survey of 1,238 consumers across 6 Asian markets found that 89% had accessed the internet for healthcare information, primarily about conditions and available treatments. While physicians remain an important source, digital channels provide a way for patients to educate themselves and get support due to time constraints with doctors. The survey showed consumers are open to various digital communication methods from healthcare providers going forward.
Internet marketing involves using websites and online promotional techniques to achieve marketing objectives. It includes using a company website along with search engines, banner ads, and other websites.
The internet can now support the entire marketing process for most businesses. Customers' decision making processes are also significantly impacted by online information. Both patients and doctors now frequently use the internet for health information and research.
WP_WhatPhysiciansWant_2014-2015_BL_WP_00120140514Betsy Lane
This survey of 245 physicians found that an increasing majority now want more traditional pharmaceutical sales representatives visiting them. For primary care physicians, over 50% now want more visits from primary care representatives, the first time a majority have indicated this preference. Physicians also want more specialty representatives and various types of nontraditional representatives. However, they expect representatives to bring high-quality information, including clinical studies and evidence-based medicine. Physicians want helpful disease and product websites as well as virtual and on-demand information, sampling, and support. Their top priority is helping patients access needed medicines and supporting patients, so they want communication and information provided in convenient, focused, and easy-to-use formats.
1) The document discusses implementing preventive healthcare programs in commercial sectors in China to create a healthier workforce. It outlines setting up educational programs to promote lifestyle changes and regular health checks.
2) A three-pronged approach is proposed involving a knowledge center, consultancy center, and planning center focused on education, monitoring, and implementation. This includes collecting health data, providing lifestyle advice and follow-up programs.
3) The presenter offers to help design educational programs, set up data collection systems, train on data analysis, and solve cultural challenges to transform approaches to preventive healthcare.
This document discusses opportunities for innovation with AVIA. It begins by outlining the author's experience in management, sales, innovation, framework development, planning, and touchpoint management. It then provides examples of cases the author has worked on, including Pfizer and Firestone. The document also summarizes the author's audit of AVIA and its market to develop ideas. It emphasizes that health care delivery needs massive-scale innovation to achieve higher performance and sustainable affordability in the face of rising costs, an aging population, new technologies, and expanding coverage.
The document summarizes the results of a survey on healthcare systems in several European countries and the US. Key findings include:
- Respondents rated their country's healthcare system quality, though Germany, Sweden, and the UK received higher ratings than Italy, Poland and the US.
- Perceptions of doctors' skills and training quality were generally positive, though sharing of information between providers needed improvement.
- Ensuring access for all citizens and managing costs for an aging population will be ongoing challenges for healthcare systems.
- Most respondents felt their country's healthcare industry contributes significantly to economic growth.
The document describes a scenario where the user is the Chief Executive of an NHS trust facing budget shortfalls that put it at risk of closing. There are three main options presented to address the problem: 1) privatize some services, 2) modernize IT systems to improve efficiency, or 3) promote healthy choices to reduce demand. Staff members provide differing perspectives on the options, with concerns about privatization reducing care quality and modernization not solving the ongoing cost of updates. The user must weigh these pros and cons while also considering a growing protest outside over the potential closure to make a final decision on the best approach.
The Sustainable Health Care Facility of the FutureTextbooks H.docxchristalgrieg
The Sustainable Health Care Facility of the Future
Textbooks:
Hayward, C. (2006). Healthcare Facility Planning: Thinking Strategically. Chicago, IL: Health Administration Press.
Vickery, C.G., Nyberg, G., & Whiteaker, D. (2015). Modern Clinic Design: Strategies for an Era of Change. Hoboken, NJ: Wiley.
Instructions: Please ensure to substantiate your response with scholarly sources and/or also a personal account of your own experience in the work place or personal life. Cite and reference work! Must be 150 -200 word count.
What reactions do you have to the ideas they presented? Include examples from the course readings or your own experience to support your perspective, and raise questions to continue the dialogue. 100 to 150 words for questions 1, 2, 6, 9, 10 & 11.
1. I agree that the changes made with CMS (center for Medicare and Medicaid Services) how changed the guidelines for how providers can bill for services. One of the biggest changes was the upgrade of ICD codes which has expanded enormously to be more specific with diagnosis and services to bill for. I work for a program of hospice, called palliative care, and the change over from using ICD9 codes to ICD10 was a very large task that took time to switch over to but I have come to realize that changes in health care are inevitable and to be prepared for things to change constantly. With being a palliative care program I don't think the change was as big of an impact on us like I'm sure it was for a hospital. Our program provides education on disease progress for chronic illnesses such a chronic kidney disease, hypertension, diabetes, cancer, heart disease and so on. The amount of ICD 10 codes we use are minimal compared to what a hospital would see. Nonetheless the codes are way more specific now which can be challenging when trying to narrow down for accuracy.
2. I think training and feedback are two important aspects of implementing electronic medical records. The users are the most important stakeholders and they should be trained properly. Their feedback should be taken seriously as this helps with post implementation changes to the system. No one likes changes but change in any organization is essential. Technology has completely transformed the health care industry and from my experience resistance typically comes from the older generation who doesn't really understand the importance. Most are used to doing things manually. Most organizations are turning to the technology to transform their environment by cutting costs and ensuring that their revenues are coming in timely.
3. Open your web browser and search for videos, articles and other resources discussing the health care system in the United States. Look for new trends, current issues affecting the health care system, etc.
4. Discuss your findings with the class
5. As a healthcare leader, you will need to have a strong base with understanding healthcare systems. Where will health care be delivered in the future? ...
US Healthcare Reform and Impact On Pharma and Healthcare IT CompaniesDr. Susan Dorfman
US Healthcare Reform and Its Impact on Pharma and Healthcare Companies:
Implications Current and Future
Presented at the Edison Ventures Pharma and Healthcare Business Solutions Executive Meeting Lawrenceville, NJ
April 20, 2010
Breaking Down Benefits: How to Leverage Data to Better Your Employees' Health...Aggregage
We need to shift away from the focus on purchasing healthcare and instead, focus on how we can create health for our employees. By incorporating dashboards in our benefits selection process, we can watch for trends in benefits and leverage that data to lower costs, retain employees, and attract new talent. Join Darrell Moon, CEO of Orriant, to learn if your benefits selection is meeting your employees' needs.
1. The document proposes a plan for a private company to generate health records and provide personalized diet plans for citizens linked to their UID number, with the goal of helping various government health programs and initiatives.
2. It describes how the company would collect health data, develop diet plans using artificial intelligence and dieticians, and provide a "smart health card" containing medical information to citizens.
3. The plan aims to financially sustain itself through partnerships with companies testing new food and pharmaceutical products, advertisements, and selling food products online, without requiring government funds. It argues this could help address various health challenges while empowering citizens.
This document discusses marketing techniques and management systems for hospitals. It covers identifying customer needs, developing programs and services to satisfy customers, and performing SWOT and PEST analyses. Various marketing strategies are presented, including the four Ps of marketing (product, place, price, promotion), addressing variables like patients, physicians, employers and lack of patient knowledge. The importance of marketing and management for hospital revenue generation is emphasized.
Similar to Opportunities and Challenges for HTA in Asia-Pacific (Part 1) (20)
The document discusses the history and context around why the United States does not have universal healthcare. It traces the evolution of the healthcare system from the early 1900s through various reforms. While many argue universal healthcare could help prevent deaths and bankruptcy, others believe it would burden taxpayers as it is not free. Historically, the US healthcare system has undergone shifts between private and public involvement through reforms. Legislatively, the checks and balances system and power of private sectors have made it difficult for universal healthcare legislation to pass due to concerns over costs and government control of the economy.
1) The introduction of smartphones in China has propelled its healthcare industry into new areas, but mHealth has not yet dominated due to issues like unmet doctor needs, poor medical coverage, and lack of trust in reliability.
2) A successful example is Sanofi's diabetes mHealth program providing rural residents access to medical experts, and helping companies understand patient needs.
3) Customizing doctor information on platforms like "Ding Xiang Yuan" and "Chunyu Yisheng" allows companies to deliver individualized options to gain insight into doctor needs in the market.
- The document compares the personalities and business strategies of the CEOs of Merck KGaA and Merck & Co.
- Merck KGaA's CEO Karl-Ludwig Kley emphasizes profit maximization and acquisitions to sustain long-term growth, while Merck & Co.'s CEO Kenneth Frazier prioritizes research and development to bring new medicines to patients.
- Despite differing approaches, both companies are now investing heavily in biopharmaceuticals to benefit healthcare systems and patients worldwide.
The insights driving superior healthcare outcomes in Asia Pacific.
Asia-Pacific Insight Magazine brings together IMS Health experts from across the region, delivering fresh perspectives on how to navigate through the challenges and opportunities in Asia-Pacific pharmaceutical market.
1. The document discusses opportunities for France and China to collaborate on improving China's healthcare system to address the country's changing demographic and economic landscape.
2. It outlines four priority areas: developing more patient-centric hospitals and health information systems, caring for an aging population, preventing and managing chronic diseases, and fighting infectious diseases.
3. France is well-positioned to offer relevant experiences and innovative solutions in these areas through its healthcare expertise, long-standing relationship with China, and companies working in areas like hospital design, elderly care, disease prevention and treatment.
The hospital segment in India is becoming increasingly attractive for pharmaceutical companies due to its large size, fast growth rate, and investment opportunities. However, pharmaceutical companies will need to rethink their business strategies to succeed in this evolving market. Hospitals are exerting more control over physician prescriptions and purchasing decisions. Additionally, the relationship between physicians and hospitals is shifting, with hospitals gaining more influence. To effectively engage with the hospital segment, pharmaceutical companies will need to tailor their strategies, products, targeting, and metrics to the unique dynamics of each hospital type.
The document provides insights into OTC market trends in the APAC region. It finds that growth in APAC comes from both innovation in new products and base sales growth, while the global market still relies heavily on price increases. Among key categories in APAC, pain relief is driving growth above the regional average, while categories like cough/cold struggle. The report also notes that just 4 of the top 10 OTC corporations in APAC are multinational companies, and only Takeda grows faster than the overall APAC market.
This document summarizes key trends in real-world evidence (RWE) research, with a focus on diabetes. It discusses how new mixed methods and analytic innovations are providing deeper insights into differential treatment responses in diabetes patient subgroups. It also describes emerging RWE strategies like disease-centric frameworks and increased commercial collaboration. Finally, it highlights advances in predictive modeling, leveraging Scandinavian data sources, and using RWE to evaluate disease burden and non-adherence impacts.
Growing Pains. China new's realities and the necessity of an informed strateg...QuintilesIMS Asia Pacific
China is a rapidly evolving healthcare market. However companies that take too macroscopic approach to projecting growth, disregarding the more granular trends across drug categories, risk facing a gap between assumed and actual portfolio growth. To address this gap, companies have a variety of options, ranging across levels of difficulty and the degree of transformation necessary.
Download the paper to learn more.
To succeed in this dynamic healthcare industry, price-volume strategies require a concerted effort from all parts of the business and close alignment with the overall strategy. Learn more about the strategies from some successful case studies in the Asia-Pacific region.
Understand more about the Awareness, Affordability and Access strategic framework to drive success for global pharma companies engaging with Asian Markets.
While progress has been made in India over the past decade from both public and private sector initiatives, significant challenges persist in providing quality healthcare on an equitable, accessible and affordable basis across all regions and communities, according to a new IMS Institute for Healthcare Informatics study. A 40-45 percent reduction in out-of-pocket expenditures for both outpatient and inpatient treatments can be attained through a holistic approach addressing four critical, interrelated dimensions of healthcare access. Those components are: physical accessibility and the location of healthcare facilities; availability and capacity of needed resources; quality and functionality of service required for patient treatment; and affordability of treatment relative to a patient’s income.
The study – Understanding Healthcare Access in India: What is the Current State? – is the most comprehensive assessment of healthcare access undertaken since 2004 and is based on an extensive survey of nearly 15,000 households covering all socio-economic groups in rural and urban areas across 12 states. Information was gathered on more than 30,000 healthcare system interactions, supplemented by interviews with over 1,000 doctors and experts.
The full report is available at http://www.theimsinstitute.org for downloading.
This presentation wil provide you the latest trends (up to March 2013) on both Global and Asia Pacific OTC markets.
This presentation is in English and Mandarine.
This document provides a global perspective on the evolving biosimilars landscape and market. It finds that after slow initial growth, the biosimilars market is poised for accelerated expansion between 2015-2020 as major biologics lose patent protection, US legislation establishes a regulatory pathway, and payers increase adoption to control costs. The market could reach $1.9-2.6 billion by 2015, up from $378 million currently, with the largest opportunities in oncology, diabetes, and rheumatoid arthritis. Key drivers include cost pressures on healthcare systems and the availability of lower-cost biosimilar alternatives to expensive biologic drugs. However, significant barriers remain due to varying regulations worldwide and resistance from biologics manufacturers.
The document summarizes the changing landscape of the top 10 pharmaceutical companies from 2002 to 2012. It notes that while the companies have remained largely the same, there has been some shuffling between positions. It also discusses how the companies have diversified their business models through mergers and acquisitions, but this has failed to increase their collective market share. The rise of Teva into the top 10 reflects a greater emphasis on generics. Overall, the top companies face challenges in innovating new blockbuster drugs and achieving growth.
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...Donc Test
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler Community Health Nursing A Canadian Perspective, 5th Edition TEST BANK by Stamler Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Study Guide Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Studocu Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Course Hero Community Health Nursing A Canadian Perspective, 5th Edition Answers Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Course hero Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Studocu Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Study Guide Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Ebook Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Questions Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Studocu Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Stuvia
Our backs are like superheroes, holding us up and helping us move around. But sometimes, even superheroes can get hurt. That’s where slip discs come in.
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
Adhd Medication Shortage Uk - trinexpharmacy.comreignlana06
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
Opportunities and Challenges for HTA in Asia-Pacific (Part 1)
1. 1
Opportunities and Challenges for HTA in Asia-Pacific
Part 1 of 2
A roundtable interview.
AUDIO INTERVIEW!
Turn on your speakers.
2. Opportunities and Challenges for HTA in Asia-Pacific
IMS Experts:
Mandy Chui, Practice Leader, Pricing and Market Access, APJ
Jonathan Tierce, GM, Health Economics & Outcomes Research
Guest Speakers:
Dr. Annie Chicoye, Associate Professor, ESSEC Santé Business
School France - Singapore
Dr. Abdulkadir Keskinaslan, Market Pricing Director, APAC,
Novartis Pharma AG Basel, Switzerland
Length: ~15 minutes
To download an MP3 of this interview, click here.
To download the PDF transcript, click here.
Questions? Comments? Fill out the form at the end of this presentation.
3. 3
Hello and welcome to the IMS Asia-Pacific Insight
interview. My name is Jonothan Tierce, the IMS General
Manager of our Health Economics and Outcomes
Research practice area. Today I am here with three
experts who are going to talk about the opportunities
and challenges for healthcare improvement and value in
the deployment of medical technologies in emerging
markets in Asia.
To download an MP3 of this interview, click here.
To download the PDF transcript, click here.
Questions? Comments? Fill out the form at the end of this presentation.
4. 4
To start, I would like to introduce Ms Mandy Chui. Mandy
is Regional Practice Leader, Pricing and Market Access at
IMS Health in Asia Pacific, where she leads engagements
to help clients in China formulate growth strategies,
optimize price and reimbursement, and address issues in
business model, sales force and marketing optimization.
Welcome Mandy.
To download an MP3 of this interview, click here.
To download the PDF transcript, click here.
Questions? Comments? Fill out the form at the end of this presentation.
Know more on IMS Health, click here
Mandy Chui (MC): Hello Jon.
5. 5
We are also joined by Dr. Annie Chicoye. Annie is an
Associate Professor at ESSEC Santé Business School
France - Singapore, with extensive experience
conducting assignments related to medicinal products
and medical devices, as well as health economics
studies, healthcare organization and networks projects.
Welcome Annie.
Annie Chicoye (AC): Thank you Jon.
To download an MP3 of this interview, click here.
To download the PDF transcript, click here.
Questions? Comments? Fill out the form at the end of this presentation.
Know more on IMS Health, click here
6. 6
And finally our third panellist – Doctor Abdulkadir
Keskinaslan. Abdulkadir is Market Pricing Director for
the Asia Pacific region at Novartis Pharma AG, Basel,
Switzerland. His professional experience encompasses
health economics activities across a range of therapies.
His recent areas of research are use of Health Economics
for Pricing and Reimbursement Decision Making and
Outcomes Based Innovative Pricing Schemes. Welcome
Abdulkadir.
Abdulkadir Keskinaslin (AK): It’s a pleasure to be here Jon.
To download an MP3 of this interview, click here.
To download the PDF transcript, click here.
Questions? Comments? Fill out the form at the end of this presentation.
Know more on IMS Health, click here
7. 7
So, let me see if I can set the context for our discussion. We
could safely say that there are three global trends impacting
healthcare worldwide. The first is the desire to improve access
to healthcare for large populations.
Second, this is accompanied by a rise in healthcare expenditure
and the potential to politicize the healthcare process.
And third, these are all set against the backdrop of a global
economic downturn, which has the industry and buyers looking
hard at how they are spending their money.
So, with that as the context, let’s turn to our panellists to learn
from their insights into how this is playing out across Asia.
To download an MP3 of this interview, click here.
To download the PDF transcript, click here.
Questions? Comments? Fill out the form at the end of this presentation.
Know more on IMS Health, click here
8. 8
Mandy, let’s start with you. What are the opportunities
and challenges in the Asia Pacific markets today?
MC: Well, Jon there are a number of opportunities we can
identify, such as an emerging middle class, particularly in
China and India. For example, the middle class (those with
annual disposable income of US5 to 15K) has been rapidly
growing from 16 mil to 124 mil households in the last 10
years, changing demographics brought on by an ageing
populations, and the movement of treatment away from
infectious disease to a rise in chronic disease such as we see
in the developed markets today. All these mean more people
are demanding more drugs and are able and willing to pay for
it.
To download an MP3 of this interview, click here.
To download the PDF transcript, click here.
Questions? Comments? Fill out the form at the end of this presentation.
Know more on IMS Health, click here
9. 9
Yes, these are positive trends for the pharma market in
APAC. So what are the challenges?
MC: Well, the biggest challenge is that most of the APAC
countries do not have sufficient government funding for
healthcare and they are non-reimbursed markets. Drugs are
still largely paid out of pocket by the individual. At the bottom
of the pile is India, typically with 80% of the health care
expenditure paid by the individual. This is followed by China
and the Philippines, with more than 50% of drug expenditure
paid by the individual.
To download an MP3 of this interview, click here.
To download the PDF transcript, click here.
Questions? Comments? Fill out the form at the end of this presentation.
Know more on IMS Health, click here
10. 10
I guess in these emerging markets, poor infrastructure
continues to be a problem as well?
MC: Yes that’s right Jon. In many of these markets they do
not even have enough doctors and hospitals and clinics to
diagnose and treat the patients. For example, there is only
one doctor per 10,000 population in Indonesia vs. 34 doctors
for the same population in Germany. Even clean water or
transportation is often not available to reach many of the
patients in the rural and very remote areas. So, patients
simply don’t have access to medical care facilities and remain
under-diagnosed and under-treated.
To download an MP3 of this interview, click here.
To download the PDF transcript, click here.
Questions? Comments? Fill out the form at the end of this presentation.
Know more on IMS Health, click here
11. 11
But healthcare reforms are ongoing in these emerging
markets?
MC: Yes that’s true. Healthcare systems are being built and
reformed across the region. Most countries are all growing
their GDP at 5% or more but healthcare spending is not
keeping pace. Thus, the government is under tremendous
pressure to improve healthcare for its citizens, especially in
providing basic healthcare or medicine to the general public.
To download an MP3 of this interview, click here.
To download the PDF transcript, click here.
Questions? Comments? Fill out the form at the end of this presentation.
Know more on IMS Health, click here
12. 12
Can you give us some examples, Mandy?
MC: Yes of course. One example is China, where they have
put together a very ambitious health care reform plan. The
Chinese government is investing 125 billion US dollars in the
next three years to broaden the access of medicine and also
health care services to its population. The government has
introduced 3 medical insurance schemes to cover 90% of its
population by 2011. However in the Philippines, funding is
still a major concern and they have implemented a number of
significant price cuts towards a lot of the top selling drugs.
To download an MP3 of this interview, click here.
To download the PDF transcript, click here.
Questions? Comments? Fill out the form at the end of this presentation.
Know more on IMS Health, click here
13. 13
And with these new burdens on the healthcare budget, is
there a concern about increased costs?
MC: Yes, and this can be seen in government initiatives to cut
prices, adopt international reference pricing, increased co-
payment from patients, and practised generic substitution.
The adoption of Health Technology Assessment, or HTA,
however, is still at its infancy in this region.
To download an MP3 of this interview, click here.
To download the PDF transcript, click here.
Questions? Comments? Fill out the form at the end of this presentation.
Know more on IMS Health, click here
14. 14
What countries are we talking about here, as an
example?
MC: Well, Korea and Taiwan are more advanced in terms of
adopting HTA to balance and optimize health care resources
and allow for innovation for the drug industry.
Thailand is the next country fast catching up. However,
countries like China or the Philippines, are still learning about
this system and have not yet put things into practice.
AC: Jon, let me build on Mandy’s point. Conceptually, HTA
definitely has been adopted as one of the ways to look at
cost-effectiveness, and other measures of product value. The
balance between providing better treatment options and
adapting new technologies is the struggle for many of the
governments in Asia.
To download an MP3 of this interview, click here.
To download the PDF transcript, click here.
Questions? Comments? Fill out the form at the end of this presentation.
Know more on IMS Health, click here
15. 15
So there is a general push to adopt HTA in these
emerging markets?
MC: There is, but the main challenge here is the lack of
expertise and talent to help the health authorities to move
this forward. There is also a shortage in terms of data; for
HTA to work, you need a lot of local data: clinical data and
healthcare resources data in order to assess cost
effectiveness of various treatment options and healthcare
resources usage.
To download an MP3 of this interview, click here.
To download the PDF transcript, click here.
Questions? Comments? Fill out the form at the end of this presentation.
Know more on IMS Health, click here
16. 16
I see. Well Asia could certainly learn from experiences in
Europe, where they have taken a long time to move from short-
term cost-containment measures to now being more focused
on looking and creating value in the system, in balancing the
health care resources. Is that right Annie?
AC: Absolutely. I can give examples of how European
governments -- with a long history of universal coverage and
raising costs -- have tried to tackle cost containment
measures, but with some concerns in the back of their minds
about industrial policy, because pharma industry has been
regarded in Europe as one of the high-tech strategic
industries that also needed to be strongly supported. So,
cost-containment measures have been developed side-by-
side with industrial policies, with the specific balance between
the two playing out in each country.
To download an MP3 of this interview, click here.
To download the PDF transcript, click here.
Questions? Comments? Fill out the form at the end of this presentation.
Know more on IMS Health, click here
17. 17
MC: It’s interesting to see the different tools that have been
used in cost containment.
AC: Yes, for example, the experience of price control in
France, profit control in the UK, prescribing budgets in
Germany and therapeutic national reference price in
Germany. Each was able to integrate HTA progressively into
the cost-containment measures to improve the efficiencies of
the health expenditure regulations and to avoid the “side
effects” of too basic cost containment measures.
To download an MP3 of this interview, click here.
To download the PDF transcript, click here.
Questions? Comments? Fill out the form at the end of this presentation.
Know more on IMS Health, click here
18. 18
Can you give us some examples of these “side effects”?
AC: Sure. For example, in France, prices for the
reimbursable drugs have been fixed by the government since
1948, but the implementation of the control for the first 35
years or so was inefficient, and not rewarding enough true
innovation. Efficiency started to be imported into the system
only in 1980, but it took time to design in collaboration with
the pharmaceutical industry some sort of predictable model
with clear rules and meanwhile other measures had to be put
in place to improve the rationality of prescriptions, for
instance by authorizing generic prescriptions by physicians
and substitution by pharmacists.
To download an MP3 of this interview, click here.
To download the PDF transcript, click here.
Questions? Comments? Fill out the form at the end of this presentation.
Know more on IMS Health, click here
19. 19
MC: So, French patients now have access to very innovative
drugs with a relatively short delay at international prices,
because now innovation is a key criteria for drug approval.
AC: That’s right Mandy. As another example, we can look at
the UK, which adopted PPRS, the Pharmaceutical Price
Regulation Scheme. Its objective was primarily to control
prices by controlling profits made on the sales through the
National Health Service, but also to favour a thriving pharma
industry. The result is that the British pharma industry has
been very productive in discovering and marketing -- at a
global level -- new drugs whereas its market value has been
kept at a much lower share of the global market.
To download an MP3 of this interview, click here.
To download the PDF transcript, click here.
Questions? Comments? Fill out the form at the end of this presentation.
Know more on IMS Health, click here
20. 20
MC: But, I understand that PPRS did not meet the need for
the best use of the limited resources allocated to the National
Health Service, so this was a problem.
AC: Yes. This is the reason why the National Institute for
Health and Clinical Excellence, or NICE, was set up in 1999
with the mission -- based on HTA methods -- to issue
recommendations to the NHS decision makers so that British
citizens would spend their health care budget in a more
optimized way. The new PPRS signed in 2009 adopts value-
based pricing to an extent.
To download an MP3 of this interview, click here.
To download the PDF transcript, click here.
Questions? Comments? Fill out the form at the end of this presentation.
Know more on IMS Health, click here
21. 21
Annie, would you say that a PPRS would be relevant in
Asia-Pac countries?
AC: There may be a connection between the regulation of
pharma expenditures that are imposed by governments and
the attractiveness of the country in terms of pharma
investments, whether it is research and development
investments or production investments. But the example of
the UK is to be really looked at very carefully. If HTA is not
carefully introduced, it may provoke aggressive pricing and it
may restrict access to care, which was actually a real issue in
the UK in the 90s before NICE was introduced.
To download an MP3 of this interview, click here.
To download the PDF transcript, click here.
Questions? Comments? Fill out the form at the end of this presentation.
Know more on IMS Health, click here
22. 22
So could we use any other country as a better example?
AC: We could look at Germany. The German government has
also been very keen on fostering a strong pharma industry
and free pricing with hardly any selection for reimbursement
has been the case for decades. But the reunification of
Germany and later on economic crisis made it necessary to
adopt cost-containment measures.
To download an MP3 of this interview, click here.
To download the PDF transcript, click here.
Questions? Comments? Fill out the form at the end of this presentation.
Know more on IMS Health, click here
23. 23
Such as?
AC: The first innovation was to fix limited budgets imposed
on prescriptions to physicians. This policy has been
implemented over many years and has had some painful side
effects, such as inviting office-based physicians in outpatient
care to refer patients to hospitals -- which is of course much
more expensive -- to avoid the costs for prescriptions which
otherwise would exceed their fixed budget.
To download an MP3 of this interview, click here.
To download the PDF transcript, click here.
Questions? Comments? Fill out the form at the end of this presentation.
Know more on IMS Health, click here
24. 24
What did they learn from this?
AC: The lesson learned is that you have to negotiate with
physicians and encourage good clinical practices before
limiting budgets in order to maintain quality care. Defining
good clinical or medical practise relies largely on HTA.
To download an MP3 of this interview, click here.
To download the PDF transcript, click here.
Questions? Comments? Fill out the form at the end of this presentation.
Know more on IMS Health, click here
25. 25
And Germany adopted therapy-based pricing. What has
been the impact of this cost-containment measure?
AC: Well, it can be viewed as successful in that it has been
adapted across Europe. In this model, prices for reimbursed
drugs remain free, but products are clustered together
because they have the same key ingredient or because they
have essentially the same therapeutic effect. Then, for all
drugs in this area, a unique tariff is set for reimbursement.
To download an MP3 of this interview, click here.
To download the PDF transcript, click here.
Questions? Comments? Fill out the form at the end of this presentation.
Know more on IMS Health, click here
26. 26
What happens if the company does not align the price to
the reimbursed tariff?
AC: If the company does not align the price to the
reimbursement tariff, it means that the patient has to pay for
the difference. And if there are alternatives, doctors would be
encouraged to prescribe the alternatives. This leads to all
prices in that therapeutic class aligning on the tariff. As a
result, this has been a very rapid and effective tool for price
decreases.
To download an MP3 of this interview, click here.
To download the PDF transcript, click here.
Questions? Comments? Fill out the form at the end of this presentation.
Know more on IMS Health, click here
27. 27
It sounds quite effective, but what are the “side
effects?”
AC: Well, firstly, not all drugs can be easily be clustered from
a clinical perspective, and it is a viable share of the
expenditure that can be covered, depending on the entry of
new drugs. Drawbacks are that companies tend to charge
more for “non-clustered” products to compensate the price
decreases on the referenced products.
To download an MP3 of this interview, click here.
To download the PDF transcript, click here.
Questions? Comments? Fill out the form at the end of this presentation.
Know more on IMS Health, click here
28. 28
Thank you for listening to part 1!
Be sure to listen to part 2, also available on SlideShare!
• To download an MP3 of this interview, click here.
• To download the PDF transcript, click here.
• Questions? Comments?
− Fill out the form at the bottom of this slide, or
− Visit www.imshealth.com or email info.sg@sg.imshealth.com.